1900 Wealth Management’s Novo Nordisk NVO Stock Holding History

1900 Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$358K	Hold	7,465	–	–	0.02%	222
2026 Q1	$274K	Buy	7,465 +1,122	+18%	+$53.2K	0.02%	224
2025 Q4	$323K	Buy	6,343 +274	+5%	+$14K	0.02%	200
2025 Q3	$337K	Buy	6,069 +45	+0.7%	+$2.63K	0.02%	186
2025 Q2	$416K	Buy	6,024 +307	+5%	+$20.9K	0.03%	161
2025 Q1	$397K	Sell	5,717 -258	-4%	-$21.3K	0.03%	165
2024 Q4	$514K	Buy	5,975 +600	+11%	+$64.9K	0.04%	137
2024 Q3	$640K	Hold	5,375	–	–	0.05%	125
2024 Q2	$767K	Sell	5,375 -826	-13%	-$109K	0.07%	109
2024 Q1	$796K	Buy	6,201 +2,321	+60%	+$276K	0.07%	119
2023 Q4	$401K	Hold	3,880	–	–	0.04%	212
2023 Q3	$353K	Buy	3,880 +302	+8%	+$26.6K	0.04%	224
2023 Q2	$290K	Sell	3,578 -1,292	-27%	-$106K	0.03%	198
2023 Q1	$330K	Hold	4,870	–	–	0.04%	194
2022 Q4	$330K	Hold	4,870	–	–	0.04%	189
2022 Q3	$243K	Hold	4,870	–	–	0.03%	204
2022 Q2	$271K	Hold	4,870	–	–	0.03%	199
2022 Q1	$270K	Buy	+4,870	New	+$250K	0.03%	212

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

1900 Wealth Management's NVO Position: Q2 2026 in Review

1900 Wealth Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 7,465 shares worth $358K. The position accounts for 0.02% of the portfolio, ranked #222.

1900 Wealth Management first reported a position in NVO in Q1 2022 and has held it in 18 quarters since. The position peaked at $796K in Q1 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

1900 Wealth Management held 7,465 shares of Novo Nordisk worth $358K as of Q2 2026.
1900 Wealth Management left its Novo Nordisk share count unchanged in Q2 2026.
Novo Nordisk made up 0.02% of 1900 Wealth Management's portfolio in Q2 2026, its #222 holding.
1900 Wealth Management first reported a position in Novo Nordisk in Q1 2022 and has held it in 18 quarters since.
1900 Wealth Management's Novo Nordisk position peaked at $796K in Q1 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on 1900 Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.